Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
FLT3, PDGFR inhibitor.
Macrolide; peptidyl transferase inhibitor, prot...
CCK antagonist.
Statin; HMG-CoA reductase inhibitor.
Calcium channel blocker.
Alkylphospholipid analog; Akt inhibitor.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
Staurosporine derivative; PKC and FLT3 inhibito...
Fluorogenic substrate used to measure serine pr...
EGFR (WT, T790M) inhibitor.
AT1 inhibitor.
SIRT2 inhibitor.
Endogenous calcitonin-family peptide frgament, ...
N-Des-2-methylpropan-2-ol Docetaxel is an impur...
Naturally produced ITC, sulfonyl analog of sulf...
Protease inhibitor.
Peptide; calcineurin inhibitor.
Peptide, protease substrate.
Purine, purvalenol A analog; CDK2, Cdc28p, Pho8...
Non-depolarizing NMJ blocker; nAChR antagonist....